Background: The American Thyroid Association (ATA), the European Association of Nuclear
Medicine, the European Thyroid Association, and the Society of Nuclear Medicine and …

Background: Publication of the 2015 American Thyroid Association (ATA) management
guidelines for adult patients with thyroid nodules and differentiated thyroid cancer was met …

Objective: To present clinical outcomes of the prospective implementation of the 2015
American Thyroid Association (ATA) guidelines for the management of thyroid nodules and …

Risk assessment is the cornerstone of contemporary management of thyroid cancer.
Following thyroid surgery, an initial risk assessment of recurrence and disease-specific …

A remarkable, evidence-based trend toward de-escalation has reformed the practice of
radioactive iodine (RAI) administration for thyroid cancer patients. Updated guidelines have …

Context Modern management of differentiated thyroid cancer requires individualized care
plans that tailor the intensity of therapy and follow-up to the estimated risks of recurrence …

Objective: The primary purpose of this study was to validate the proposed modified 2009
American Thyroid Association Risk Stratification System (M-2009-RSS) in patients with …

The treatment of differentiated thyroid cancer continues to move away from a 'one size fits
all'approach to a process of tailored therapeutic decision-making that incorporates disease …

The main clinical challenge in the management of thyroid cancer is to avoid over-treatment
and over-diagnosis in patients with lower-risk disease while promptly identifying those …

The lack of prospective randomized clinical trials for most management topics in
differentiated thyroid cancer forces us to make management recommendations based on …